Lentiviral human BNIP2 sgRNA gene knockout kit

Lentiviral human BNIP2 sgRNA gene knockout kit

Catalog Number:
CGKK546370FEN
Mfr. No.:
HKO-610940
Price:
$878
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Kit Components: Lentiviral particles or plasmids for a set of three sgRNAs, and a pair of Indel screening PCR primers

          sgRNA lentiviral particle information
          • Functional titer: 1x10^8 TU/ml
          • Titration method: counting puromycin resistant cell clones
          • Purity: In vivo grade
          • Pseudotype: VSVG
          • Storage buffer: LentiShield™ lentivirus storage buffer
          • Storage: condition -80°C
          • Availability: 3-5 weeks

          sgRNA lentiviral plasmid information
          • Promoter for target sgRNA: U6
          • Mammalian selection: puromycin
          • Promoter for mammalian selection gene: EF1a
          • E.coli selection: Amp
          • Storage condition: -20°C
          • Availability: 1-2 weeks

          Please contact us at for specific academic pricing.

          Target Information

          Target Name
          Human BNIP2
          About Target
          Gene symbol: BNIP2
          Synonyms: BNIP-2 NIP2
          Species: HUMAN
          Gene ID: 663
          Summary: This gene is a member of the BCL2/adenovirus E1B 19 kd-interacting protein (BNIP) family. It interacts with the E1B 19 kDa protein, which protects cells from virally-induced cell death. The encoded protein also interacts with E1B 19 kDa-like sequences of BCL2, another apoptotic protector. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016].
          NM numbers targeted (Accession number:Exon:CDS Fragment): NM_001320674:5:4 NM_004330:5:4 NM_001320675:5:5 NM_001368057:5:4 NM_001368058:4:2 NM_001368059:5:4 NM_001368060:4:2 NM_001368061:5:4
      • Properties
        • * For Research Use Only.

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.